SCM

Sio Capital Management Portfolio holdings

AUM $249M
This Quarter Return
+16.38%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$478M
AUM Growth
+$478M
Cap. Flow
-$13.6M
Cap. Flow %
-2.84%
Top 10 Hldgs %
39.23%
Holding
111
New
20
Increased
19
Reduced
33
Closed
21

Top Buys

1
CNC icon
Centene
CNC
$13.9M
2
CI icon
Cigna
CI
$10.8M
3
MRK icon
Merck
MRK
$9.64M
4
ICLR icon
Icon
ICLR
$9.33M
5
GSK icon
GSK
GSK
$9.19M

Top Sells

1
AZN icon
AstraZeneca
AZN
$13.1M
2
COR icon
Cencora
COR
$12.5M
3
WBA
Walgreens Boots Alliance
WBA
$12.3M
4
SNY icon
Sanofi
SNY
$10.7M
5
AMGN icon
Amgen
AMGN
$9.2M

Sector Composition

1 Healthcare 90.08%
2 Consumer Staples 1.38%
3 Technology 0.69%
4 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EUCRU
51
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$3M 0.61%
300,000
– –
NBSE
52
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2.91M 0.59%
393,699
+100,000
+34% +$739K
OBIO icon
53
Orchestra BioMed
OBIO
$148M
$2.8M 0.57%
250,000
– –
LRMR icon
54
Larimar Therapeutics
LRMR
$340M
$2.74M 0.56%
187,223
-1,438
-0.8% -$21K
ONCT
55
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2.69M 0.55%
323,333
– –
FUSN
56
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.67M 0.54%
249,419
+76,726
+44% +$823K
PRQR icon
57
ProQR Therapeutics
PRQR
$243M
$2.6M 0.53%
+392,821
New +$2.6M
CBAY
58
DELISTED
Cymabay Therapeutics
CBAY
$2.55M 0.52%
562,339
-25,000
-4% -$113K
MRSN icon
59
Mersana Therapeutics
MRSN
$37.6M
$2.54M 0.52%
157,259
-27,700
-15% -$448K
GOSS icon
60
Gossamer Bio
GOSS
$607M
$2.42M 0.49%
+261,400
New +$2.42M
FULC icon
61
Fulcrum Therapeutics
FULC
$352M
$2.25M 0.46%
191,272
+45,000
+31% +$530K
VINC
62
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.03M 0.41%
105,000
-44,892
-30% -$867K
BCEL
63
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.74M 0.35%
113,455
-15,000
-12% -$230K
RVLP
64
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.69M 0.34%
+519,039
New +$1.69M
AVTX icon
65
Avalo Therapeutics
AVTX
$120M
$1.67M 0.34%
552,241
-375,505
-40% -$1.13M
ANIK icon
66
Anika Therapeutics
ANIK
$135M
$1.63M 0.33%
40,000
-25,382
-39% -$1.04M
RUBY
67
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.59M 0.32%
+59,800
New +$1.59M
ARNA
68
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.51M 0.31%
21,738
-36,000
-62% -$2.5M
MEIP icon
69
MEI Pharma
MEIP
$158M
$1.46M 0.3%
426,047
– –
HROW icon
70
Harrow
HROW
$1.38B
$1.42M 0.29%
209,623
– –
IOVA icon
71
Iovance Biotherapeutics
IOVA
$807M
$1.41M 0.29%
44,430
-9,570
-18% -$303K
SRRA
72
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.4M 0.28%
80,952
+14,497
+22% +$250K
AHACU
73
DELISTED
Alpha Healthcare Acquisition Corp. Unit
AHACU
$1.25M 0.25%
100,000
– –
SIOX
74
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.2M 0.24%
460,248
-426,417
-48% -$1.11M
ETON icon
75
Eton Pharmaceutcials
ETON
$466M
$1.19M 0.24%
+162,659
New +$1.19M
1 2
3
4 5